ProShare Advisors’s Mineralys Therapeutics MLYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$141K	Buy	+10,457	New	+$141K	﹤0.01%	1802
2025 Q1	–	Sell	-10,405	Closed	-$128K	–	2189
2024 Q4	$128K	Buy	+10,405	New	+$128K	﹤0.01%	2014